A Prospective, Pilot Trial to Evaluate Safety and Tolerability of Everolimus for the Prevention of BK and CMV Viremia in HLA Sensitized Kidney Transplant Recipients
Phase of Trial: Phase II
Latest Information Update: 11 Dec 2017
At a glance
- Drugs Everolimus (Primary) ; Tacrolimus
- Indications Cytomegalovirus infections; Polyomavirus infections; Renal transplant rejection
- Focus Therapeutic Use
- 03 Dec 2017 Status changed from active, no longer recruiting to completed.
- 08 Feb 2016 Planned End Date changed from 1 Jun 2015 to 1 Jul 2016 as reported by ClinicalTrials.gov record.
- 08 Feb 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.